[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Z Squared Inc (ZSQR)

Z Squared Inc (ZSQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Z Squared Inc 550 SOUTH ANDREWS AVE. SUITE 700 FORT LAUDERDALE FL 33301 USA

https://coeptistx.com Employees: 6 P: 954-400-9994

Description:

Coeptis Therapeutics Holdings Inc., together with its subsidiaries including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals Inc., is a biopharmaceutical company developing innovative cell therapy platforms for cancer. Coeptis Therapeutics Holdings Inc., formerly known as Bull Horn Holdings Corp., is based in WEXFORD, Pa.

Key Statistics

Overview:

Market Capitalization, $K 565,227
Enterprise Value, $K 559,707
Shares Outstanding, K 51,431
Float, K 38,959
% Float 75.75%
Short Interest, K 1,130
Short Float 2.20%
Days to Cover 4.05
Short Volume Ratio 0.83
% of Insider Shareholders 24.25%
% of Institutional Shareholders 13.88%

Financials:

Annual Sales, $ 1,360 K
Annual Net Income, $ -11,920 K
Last Quarter Sales, $ 110 K
Last Quarter Net Income, $ -3,920 K
EBIT, $ -12,900 K
EBITDA, $ -11,170 K

Growth:

1-Year Return 46.93%
3-Year Return -65.44%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.65 on 05/14/26
Next Earnings Date 08/13/26
Earnings Per Share ttm -2.52
EPS Growth vs. Prev Qtr -441.67%
EPS Growth vs. Prev Year 41.44%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 12/31/24

ZSQR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -92.29%
Return-on-Assets % -73.52%
Profit Margin % -876.47%
Debt/Equity 0.01
Price/Sales 453.56
Price/Cash Flow N/A
Price/Book 4.48
Book Value/Share 2.68
Interest Coverage -121.80
60-Month Beta -0.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.